211 related articles for article (PubMed ID: 25201782)
1. Fully automated atlas-based hippocampal volumetry for detection of Alzheimer's disease in a memory clinic setting.
Suppa P; Anker U; Spies L; Bopp I; Rüegger-Frey B; Klaghofer R; Gocke C; Hampel H; Beck S; Buchert R
J Alzheimers Dis; 2015; 44(1):183-93. PubMed ID: 25201782
[TBL] [Abstract][Full Text] [Related]
2. Fully Automated Atlas-Based Hippocampus Volumetry for Clinical Routine: Validation in Subjects with Mild Cognitive Impairment from the ADNI Cohort.
Suppa P; Hampel H; Spies L; Fiebach JB; Dubois B; Buchert R;
J Alzheimers Dis; 2015; 46(1):199-209. PubMed ID: 25720402
[TBL] [Abstract][Full Text] [Related]
3. Performance of Hippocampus Volumetry with FSL-FIRST for Prediction of Alzheimer's Disease Dementia in at Risk Subjects with Amnestic Mild Cognitive Impairment.
Suppa P; Hampel H; Kepp T; Lange C; Spies L; Fiebach JB; Dubois B; Buchert R;
J Alzheimers Dis; 2016; 51(3):867-73. PubMed ID: 26923010
[TBL] [Abstract][Full Text] [Related]
4. Association between fully automated MRI-based volumetry of different brain regions and neuropsychological test performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.
Arlt S; Buchert R; Spies L; Eichenlaub M; Lehmbeck JT; Jahn H
Eur Arch Psychiatry Clin Neurosci; 2013 Jun; 263(4):335-44. PubMed ID: 22940716
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of Alzheimer's disease-related individual structural volume measurements using IBASPM.
Han SH; Lee MA; An SS; Ahn SW; Youn YC; Park KY
J Clin Neurosci; 2014 Dec; 21(12):2165-9. PubMed ID: 25150766
[TBL] [Abstract][Full Text] [Related]
6. A comparison between the accuracy of voxel-based morphometry and hippocampal volumetry in Alzheimer's disease.
Testa C; Laakso MP; Sabattoli F; Rossi R; Beltramello A; Soininen H; Frisoni GB
J Magn Reson Imaging; 2004 Mar; 19(3):274-82. PubMed ID: 14994294
[TBL] [Abstract][Full Text] [Related]
7. Multi-atlas segmentation of the whole hippocampus and subfields using multiple automatically generated templates.
Pipitone J; Park MT; Winterburn J; Lett TA; Lerch JP; Pruessner JC; Lepage M; Voineskos AN; Chakravarty MM;
Neuroimage; 2014 Nov; 101():494-512. PubMed ID: 24784800
[TBL] [Abstract][Full Text] [Related]
8. Standardization of hippocampus volumetry using automated brain structure volumetry tool for an initial Alzheimer's disease imaging biomarker.
Abrigo J; Shi L; Luo Y; Chen Q; Chu WCW; Mok VCT;
Acta Radiol; 2019 Jun; 60(6):769-776. PubMed ID: 30185071
[TBL] [Abstract][Full Text] [Related]
9. Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease.
Teipel SJ; Grothe M; Lista S; Toschi N; Garaci FG; Hampel H
Med Clin North Am; 2013 May; 97(3):399-424. PubMed ID: 23642578
[TBL] [Abstract][Full Text] [Related]
10. Automated 3D segmentation of hippocampus based on active appearance model of brain MR images for the early diagnosis of Alzheimer's disease.
Luo ZR; Zhuang XJ; Zhang RZ; Wang JQ; Yue C; Huang X
Minerva Med; 2014 Apr; 105(2):157-65. PubMed ID: 24727880
[TBL] [Abstract][Full Text] [Related]
11. Combination of MRI hippocampal volumetry and arterial spin labeling MR perfusion at 3-Tesla improves the efficacy in discriminating Alzheimer's disease from cognitively normal elderly adults.
Mak HK; Qian W; Ng KS; Chan Q; Song YQ; Chu LW; Yau KK
J Alzheimers Dis; 2014; 41(3):749-58. PubMed ID: 24670395
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease diagnosis based on the Hippocampal Unified Multi-Atlas Network (HUMAN) algorithm.
Amoroso N; Rocca M; Bellotti R; Fanizzi A; Monaco A; Tangaro S;
Biomed Eng Online; 2018 Jan; 17(1):6. PubMed ID: 29357893
[TBL] [Abstract][Full Text] [Related]
13. Discrimination between Alzheimer disease, mild cognitive impairment, and normal aging by using automated segmentation of the hippocampus.
Colliot O; Chételat G; Chupin M; Desgranges B; Magnin B; Benali H; Dubois B; Garnero L; Eustache F; Lehéricy S
Radiology; 2008 Jul; 248(1):194-201. PubMed ID: 18458242
[TBL] [Abstract][Full Text] [Related]
14. Manual validation of FreeSurfer's automated hippocampal segmentation in normal aging, mild cognitive impairment, and Alzheimer Disease subjects.
Sánchez-Benavides G; Gómez-Ansón B; Sainz A; Vives Y; Delfino M; Peña-Casanova J
Psychiatry Res; 2010 Mar; 181(3):219-25. PubMed ID: 20153146
[TBL] [Abstract][Full Text] [Related]
15. Automated method for identification of patients with Alzheimer's disease based on three-dimensional MR images.
Arimura H; Yoshiura T; Kumazawa S; Tanaka K; Koga H; Mihara F; Honda H; Sakai S; Toyofuku F; Higashida Y
Acad Radiol; 2008 Mar; 15(3):274-84. PubMed ID: 18280925
[TBL] [Abstract][Full Text] [Related]
16. A direct morphometric comparison of five labeling protocols for multi-atlas driven automatic segmentation of the hippocampus in Alzheimer's disease.
Nestor SM; Gibson E; Gao FQ; Kiss A; Black SE;
Neuroimage; 2013 Feb; 66():50-70. PubMed ID: 23142652
[TBL] [Abstract][Full Text] [Related]
17. Combining viscoelasticity, diffusivity and volume of the hippocampus for the diagnosis of Alzheimer's disease based on magnetic resonance imaging.
Gerischer LM; Fehlner A; Köbe T; Prehn K; Antonenko D; Grittner U; Braun J; Sack I; Flöel A
Neuroimage Clin; 2018; 18():485-493. PubMed ID: 29527504
[TBL] [Abstract][Full Text] [Related]
18. Hippocampal Subfield Volumetry and 3D Surface Mapping in Subjective Cognitive Decline.
Perrotin A; de Flores R; Lamberton F; Poisnel G; La Joie R; de la Sayette V; Mézenge F; Tomadesso C; Landeau B; Desgranges B; Chételat G
J Alzheimers Dis; 2015 Sep; 48 Suppl 1():S141-50. PubMed ID: 26402076
[TBL] [Abstract][Full Text] [Related]
19. Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer's disease.
Mielke MM; Okonkwo OC; Oishi K; Mori S; Tighe S; Miller MI; Ceritoglu C; Brown T; Albert M; Lyketsos CG
Alzheimers Dement; 2012; 8(2):105-13. PubMed ID: 22404852
[TBL] [Abstract][Full Text] [Related]
20. The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium study.
Bosco P; Redolfi A; Bocchetta M; Ferrari C; Mega A; Galluzzi S; Austin M; Chincarini A; Collins DL; Duchesne S; Maréchal B; Roche A; Sensi F; Wolz R; Alegret M; Assal F; Balasa M; Bastin C; Bougea A; Emek-Savaş DD; Engelborghs S; Grimmer T; Grosu G; Kramberger MG; Lawlor B; Mandic Stojmenovic G; Marinescu M; Mecocci P; Molinuevo JL; Morais R; Niemantsverdriet E; Nobili F; Ntovas K; O'Dwyer S; Paraskevas GP; Pelini L; Picco A; Salmon E; Santana I; Sotolongo-Grau O; Spiru L; Stefanova E; Popovic KS; Tsolaki M; Yener GG; Zekry D; Frisoni GB
Alzheimers Dement; 2017 Sep; 13(9):1013-1023. PubMed ID: 28263741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
